153 related articles for article (PubMed ID: 21440656)
1. Ruthenium-nitrite complex as pro-drug releases NO in a tissue and enzyme-dependent way.
Pereira Ade C; Ford PC; da Silva RS; Bendhack LM
Nitric Oxide; 2011 May; 24(4):192-8. PubMed ID: 21440656
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide generated by the compound RuBPY promotes the vascular smooth cell membrane hyperpolarization.
Pereira AC; Lunardi CN; Paulo M; da Silva RS; Bendhack LM
Eur J Pharm Sci; 2013 Mar; 48(4-5):604-10. PubMed ID: 23333503
[TBL] [Abstract][Full Text] [Related]
3. The 2-nitrate-1,3-dibuthoxypropan, a new nitric oxide donor, induces vasorelaxation in mesenteric arteries of the rat.
França-Silva MS; Luciano MN; Ribeiro TP; Silva JS; Santos AF; França KC; Nakao LS; Athayde-Filho PF; Braga VA; Medeiros IA
Eur J Pharmacol; 2012 Sep; 690(1-3):170-5. PubMed ID: 22796675
[TBL] [Abstract][Full Text] [Related]
4. Effects of a novel guanylyl cyclase inhibitor on the vascular actions of nitric oxide and peroxynitrite in immunostimulated smooth muscle cells and in endotoxic shock.
Zingarelli B; Haskó G; Salzman AL; Szabó C
Crit Care Med; 1999 Sep; 27(9):1701-7. PubMed ID: 10507586
[TBL] [Abstract][Full Text] [Related]
5. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity.
Galle J; Zabel U; Hübner U; Hatzelmann A; Wagner B; Wanner C; Schmidt HH
Br J Pharmacol; 1999 May; 127(1):195-203. PubMed ID: 10369473
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in rat tracheal smooth muscle.
Toque HA; Mónica FZ; Morganti RP; De Nucci G; Antunes E
Eur J Pharmacol; 2010 Oct; 645(1-3):158-64. PubMed ID: 20670622
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the mechanisms underlying the relaxation induced by two nitric oxide donors: sodium nitroprusside and a new ruthenium complex.
Bonaventura D; de Lima RG; Vercesi JA; da Silva RS; Bendhack LM
Vascul Pharmacol; 2007 Mar; 46(3):215-22. PubMed ID: 17127100
[TBL] [Abstract][Full Text] [Related]
8. Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.
Nimmegeers S; Sips P; Buys E; Brouckaert P; Van de Voorde J
Cardiovasc Res; 2007 Oct; 76(1):149-59. PubMed ID: 17610859
[TBL] [Abstract][Full Text] [Related]
9. Heme proteins mediate the conversion of nitrite to nitric oxide in the vascular wall.
Alzawahra WF; Talukder MA; Liu X; Samouilov A; Zweier JL
Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H499-508. PubMed ID: 18539756
[TBL] [Abstract][Full Text] [Related]
10. Relaxant effect of a water soluble carbon monoxide-releasing molecule (CORM-3) on spontaneously hypertensive rat aortas.
Failli P; Vannacci A; Di Cesare Mannelli L; Motterlini R; Masini E
Cardiovasc Drugs Ther; 2012 Aug; 26(4):285-92. PubMed ID: 22766583
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of the vasodilating effect induced by the ruthenium complex cis-[Ru(NO)(NO2)(bpy)2].(PF6)2.
Rodrigues GJ; Pereira AC; de Moraes TF; Wang CC; da Silva RS; Bendhack LM
J Cardiovasc Pharmacol; 2015 Feb; 65(2):168-75. PubMed ID: 25384194
[TBL] [Abstract][Full Text] [Related]
12. Vasorelaxation induced by the new nitric oxide donor cis-[Ru(Cl)(bpy)(2)(NO)](PF(6)) is due to activation of K(Ca) by a cGMP-dependent pathway.
Lunardi CN; Vercesi JA; da Silva RS; Bendhack LM
Vascul Pharmacol; 2007; 47(2-3):139-44. PubMed ID: 17602893
[TBL] [Abstract][Full Text] [Related]
13. NO donors induce vascular relaxation by different cellular mechanisms in hypertensive and normotensive rats.
Araújo AV; Andrade FA; Paulo M; de Paula TD; Potje SR; Pereira AC; Bendhack LM
Nitric Oxide; 2019 May; 86():12-20. PubMed ID: 30772501
[TBL] [Abstract][Full Text] [Related]
14. Effects induced by inhibitors of the phosphatidylinositol 3-kinase/Akt and nitric oxide synthase/guanylyl cyclase pathways on the isometric contraction in rat aorta: a comparative study.
López RM; Pérez T; Castillo C; Castillo EF
Fundam Clin Pharmacol; 2011 Jun; 25(3):313-22. PubMed ID: 20584208
[TBL] [Abstract][Full Text] [Related]
15. The mechanism of vasorelaxation induced by ethanol extract of Sophora flavescens in rat aorta.
Jin SN; Wen JF; Li X; Kang DG; Lee HS; Cho KW
J Ethnopharmacol; 2011 Sep; 137(1):547-52. PubMed ID: 21704693
[TBL] [Abstract][Full Text] [Related]
16. Type 1 diabetes and hypercholesterolaemia reveal the contribution of endothelium-derived hyperpolarizing factor to endothelium-dependent relaxation of the rat aorta.
Malakul W; Thirawarapan S; Suvitayavat W; Woodman OL
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):192-200. PubMed ID: 17941894
[TBL] [Abstract][Full Text] [Related]
17. Relaxation to authentic nitric oxide and SIN-1 in rat isolated mesenteric arteries: variable role for smooth muscle hyperpolarization.
Plane F; Sampson LJ; Smith JJ; Garland CJ
Br J Pharmacol; 2001 Jul; 133(5):665-72. PubMed ID: 11429390
[TBL] [Abstract][Full Text] [Related]
18. Differential sensitivity among nitric oxide donors toward ODQ-mediated inhibition of vascular relaxation.
Tseng CM; Tabrizi-Fard MA; Fung HL
J Pharmacol Exp Ther; 2000 Feb; 292(2):737-42. PubMed ID: 10640313
[TBL] [Abstract][Full Text] [Related]
19. Selective guanylyl cyclase inhibitor reverses nitric oxide-induced vasorelaxation.
Olson LJ; Knych ET; Herzig TC; Drewett JG
Hypertension; 1997 Jan; 29(1 Pt 2):254-61. PubMed ID: 9039111
[TBL] [Abstract][Full Text] [Related]
20. Redox variants of NO (NO{middle dot} and HNO) elicit vasorelaxation of resistance arteries via distinct mechanisms.
Favaloro JL; Kemp-Harper BK
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1274-80. PubMed ID: 19252101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
